Team Identifies Switch For Tumor Suppressor Gene

Scientists have identified the protein that determines whether or not a tumor suppressor gene is able to do its job of slowing down or stopping cell growth. The work is a first step toward better control over a gene that plays a role in many cases of human cancer.

The research by a team from the University of Rochester Cancer Center is on the retinoblastoma (RB) gene, one of the first known in a class of genes known as tumor suppressors, whose job it is to rein in cell growth. The work, by Associate Professor John Ludlow, graduate student Deidre Nelson, and post- doctoral researcher Nancy Krucher, appears in the Feb. 14 issue of the Journal of Biological Chemistry.

Cancer is a tale of cells growing out of control, and genes that make proteins that speed up or slow down cell growth are often pivotal in the disease. One such gene codes for the RB protein, which suppresses cell growth. The RB protein is present in all healthy cells, but a mutation can lead to cancer. If this mutation occurs in cells destined to form the eye, a rare but deadly form of childhood eye cancer known as retinoblastoma occurs. More commonly, the gene is missing or mutated in many types of cancer cells such as those found in the lung, breast, and ovary.

"In all cancers, you have cells that proliferate uncontrollably," says Ludlow, the lead investigator and co-author of the book, Tumor Suppressors: Involvement in Human Diseases, Viral Protein Interactions, and Growth Regulation. "We all hope that in the future, we'll be able to put the brakes on runaway cancer cells. One way of doing that may be to control a cell's proliferation through manipulation of the RB protein."

The Rochester group has identified the protein that activates RB to slow down cell proliferation. The protein, known as PP1c, does its work during a very narrow time frame during mitosis, when a cell is dividing.

PP1c turns on RB through a chemical process known as de- phosp

Contact: Tom Rickey
University of Rochester

Page: 1 2

Related biology news :

1. UCSF Team Identifies Two Key Molecules In Asthma; Important Finding For New Therapies That Treat Disease At Cell Level
2. Idun Pharmaceuticals Identifies Cell Type And Molecular Pathway Involved In TransplantationRelated Liver Damage
3. Leading HIV Researcher Identifies Molecular Mechanism That Enhances NaturalImmune Defense Against HIV Infection
4. Researcher Identifies Two New Violet Species In Central America
5. Switching off Huntingtons
6. Switching on the fly genome
7. Computer Simulation Reveals Nano-Switch That Activates Cell-Binding Function Of Key Protein In The Body
8. Adult Cells Undergo Identity Switch Reported In Science
9. Master Switch May Help Cancer Cells Hide From Immune System
10. Clues To Molecular Cancer Switches Probed
11. A Protein Switch May Turn On Heart Cells To Combat Heart Disease

Post Your Comments:

(Date:7/1/2020)... ... 01, 2020 , ... Catalent, a global leader in clinical ... packaging facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating ... the new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for biopharmaceutical R&D, today announced that it has entered into a multi-year ... antibodies (Multiclonics®), to support their translational and clinical research strategy to discover ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC ... services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ... patients with severe COVID-19. This is the first study of an XPO1 inhibitor ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter maintenance and ... successful study, while protecting and accessing the catheter or device post-surgery is often undervalued ... Envigo in a live webinar on Wednesday, August 5, 2020 at ...
(Date:7/18/2020)... ... 2020 , ... dicentra , a leading Contract Research ... is pleased to announce that Charles Galea has joined its clinical trials division ... an accomplished and results-driven sales executive with over 10 years of expertise in ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most ... used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate ... Dr MA has been using the zebrafish model to investigate the causes of ...
(Date:7/7/2020)... BOSTON (PRWEB) , ... July 06, 2020 , ... ... Innovative Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of ... Since 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples ...
Breaking Biology Technology:
Cached News: